The Caris Molecular Intelligence® comprehensive tumor profiling approach to assess DNA, RNA, and proteins reveals the highest quality molecular blueprint provide evidence-based selection of the most appropriate cancer therapy. Among our most cutting edge approaches is the utilization of artificial intelligence algorithms to make predictions of benefit from standard treatments, including chemotherapy. We are the original and most experienced comprehensive tumor profiling laboratory and have optimized our workflows to provide an industry-leading turnaround time of 10-14 days.
Unlike other tumor profiling services on the market, we use the best available technologies for biomarker identification. This approach allows our medical teams to more fully understand the biology of the tumor, which helps our oncologist colleagues plan their treatment strategy.
We help you find the best answers when you need them most
Connecting patients with the most up-to-date and relevant clinical trials
Caris helps patients access the best possible treatment